We’ve built a team with unparalleled technical acumen and industry expertise to guide our course.

Leadership Team

Jim Broderick, M.D.
CEO and Founder
Li Peng, Ph.D.
Chief Scientific Officer
David Feltquate, M.D., Ph.D.
Clinical Consultant, Immune Oncology
Bob Sikorski, M.D., Ph.D.,
Clinical Consultant, Oncology
Puneet Arora, M.D., M.S.
Clinical Consultant, Autoimmunity

Board of Directors

Jim Broderick, M.D.
Palleon Pharmaceuticals
Deepa Pakianathan, Ph.D.
Independent Member
David Johnson
Independent Member
Karan Takhar
Matrix Capital Management
Alan Colowick, M.D., MPH
Matrix Capital Management
Denis Patrick, Ph.D.
Pfizer
Rajeev Dadoo, Ph.D.
SR One

Scientific Advisors

Carolyn Bertozzi, Ph.D.
Stanford University
Paul Crocker, Ph.D.
University of Dundee
James Paulson, Ph.D.
Scripps Research Institute
Stephan von Gunten, M.D., Ph.D.
University of Bern
Jeffrey Ravetch, Ph.D.
Rockefeller University
Peter Murray, Ph.D.
Max Planck Institute

Senior R&D Advisors

Rakesh Dixit, Ph.D.
Senior Consultant, Safety/Toxicology
Rob Kramer, Ph.D.
Senior Consultant, Research & Development

Founders

Jim Broderick, M.D.
CEO and Founder
Carolyn Bertozzi, Ph.D.
Co-Founder
Paul Crocker, Ph.D.
Co-Founder